$1.70
+0.03 (+1.80%)
Open$1.67
Previous Close$1.67
Day High$1.78
Day Low$1.65
52W High$38.43
52W Low$15.70
Volume—
Avg Volume696.7K
Market Cap148.59M
P/E Ratio48.57
EPS$0.55
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+1,508.8% upside
Current
$1.70
$1.70
Target
$27.35
$27.35
$22.03
$27.35 avg
$42.34
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 24.41M | 24.82M | 19.44M |
| Net Income | -1,389,193 | -1,166,783 | -1,174,826 |
| Profit Margin | -5.7% | -4.7% | -6.0% |
| EBITDA | -1,777,503 | -1,974,923 | -1,572,213 |
| Free Cash Flow | -1,484,406 | -1,631,995 | -1,127,049 |
| Rev Growth | +22.2% | +16.0% | +16.0% |
| Debt/Equity | 0.27 | 0.31 | 0.33 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |